Document Detail


Treating Depression in Coronary Artery Disease and Chronic Heart Failure. What's new in using Selective Serotonin Re-Uptake Inhibitors?
MedLine Citation:
PMID:  22471956     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Depression is a common co-morbidity in patients with cardiovascular diseases such as chronic coronary artery disease, acute coronary syndromes, post by-pass surgery and chronic heart failure. The presence of depression is independently associated with a decline in health status and an increase in the risk of hospitalization and death for patients with coronary artery disease or congestive heart failure. Novel treatment modalities such as selective serotonin re-uptake inhibitors (SSRIs) may improve depressive symptoms and prognosis of post-myocardial infarction and heart failure patients interacting with the common pathophysiological mechanisms of depression and cardiovascular disease. This review summarizes current experimental and clinical evidence regarding the effects of SSRIs on platelet functions, immune and neurohormonal activation, and cardiac rhythm disturbances in patients with cardiovascular disease.
Authors:
I Paraskevaidis; J Palios; J Parissis; G Filippatos; M Anastasiou-Nana
Related Documents :
6306086 - Right ventricular ejection fraction: an indicator of increased mortality in patients wi...
1652196 - Impairment of left ventricular function during coronary angioplastic occlusion evaluate...
2529056 - Functional significance of hypertrophy of the noninfarcted myocardium after myocardial ...
18849396 - Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.
6637766 - Decrease in thallium-201 image defect size after permanent coronary occlusion.
8873666 - Radiofrequency catheter ablation of right ventricular tachycardia late after repair of ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-2
Journal Detail:
Title:  Cardiovascular & hematological agents in medicinal chemistry     Volume:  -     ISSN:  1875-6182     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101266881     Medline TA:  Cardiovasc Hematol Agents Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Rimini 1, Haidari, 12462, Athens, Greece. ioannispalios@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Atopic Dermatitis in African American Children: Addressing Unmet Needs of a Common Disease.
Next Document:  PPAR- ? Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations.